跳至主要内容
临床试验/NL-OMON50393
NL-OMON50393尚未招募不适用

Gut Microbiome Analysis in de Novo Parkinson's Patients - DUPARM

niversitair Medisch Centrum Groningen0 个研究点目标入组 480 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
480

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • All participants:
  • - Written informed consent
  • Study group:
  • - Diagnosed Parkinson*s disease according to the UK Parkinson*s Disease Society
  • Brain Bank Criteria
  • Control group:
  • - Healthy sex- and age-matched controls, also matched according to presence and
  • severity of constipation.

排除标准

  • All participants:
  • Gastrointestinal exclusion criteria:
  • - Active or persistent primary disease of the gastrointestinal tract
  • - History of peritonitis, severe endometriosis, abdominal, intestinal or
  • urogenital fistula,
  • - Hepatobiliar or pancreatic disease (except asymptomatic cholecystolithiasis)
  • - History of abdominal or anorectal surgery, except minor surgery such as
  • uncomplicated appendectomy or cholecystectomy (>6 months ago)
  • - Severe gynaecological prolapse (grade III)
  • - Cancer and/or adjuvant treatment within the last 6 months
  • - Within the last three months: narcosis, analgosedation, endoscopic procedure
  • of the gastrointestinal tract, abdominal trauma
  • - Within the last three months: gastrointestinal tract infection, food
  • intoxication,
  • Study group:
  • - History of dopaminergic medication use
  • Control group:
  • - History of neurodegenerative disease, in particular signs of parkinsonism.
  • - Probable prodromal PD. Controls will, however, be matched according to
  • presence and severity of constipation as a possible confounder.

研究者

相似试验

Gut Microbiome Analysis in de Novo Parkinson's... | 临床试验